Clinical Trial Update: Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the feasibility outcomes of the LUM Imaging System for peritoneal metastases in a Phase 1/2 study conducted by Lumicell, Inc.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Metastases

Snippet

Sponsor: Lumicell, Inc. | Conditions: Peritoneal Metastases | Phase 1, Phase 2 | Status: COMPLETED